Genomic Screening can Help Detect Medullary Thyroid Cancer, Study Finds
Population-based genomic screening facilitates early detection of medullary thyroid cancer (MTC) in patients with variants in the RET gene.
Population-based genomic screening facilitates early detection of medullary thyroid cancer (MTC) in patients with variants in the RET gene.
Viome Life Sciences, a biotechnology company, unveiled its CancerDetect test for oral & throat cancer, the first launch in a series of diagnostic tests in development.
Mercy BioAnalytics' Mercy Halo Ovarian Cancer assay outperformed CA125 when identifying those with early high-grade serious ovarian cancer.
Researchers are developing a low-cost handheld device that could cut the rate of unnecessary skin biopsies in half.
Read MoreResearch indicates that testing an individual’s blood can reveal the presence of circulating melanoma cells, indicating skin cancer.
Read MoreA study by UC San Francisco underscores the critical role of genomic profiling in brain tumor diagnosis and grading.
Read MoreResearchers have developed a new urine test for bladder cancer, which could significantly cut the need for invasive cystoscopies.
Read MoreResearchers have developed a PCR test for mouth cancer, which only requires machines used in COVID testing and a technician to operate it.
Read MoreLearn how CLP’s editor discovered firsthand how clinical laboratories and laboratorians are being taken for granted.
Read MoreIt may be possible to identify the presence of an aggressive brain tumor in children by studying their cerebrospinal fluid, according to new research.
Read MoreBlood tests for the detection of circulating tumor DNA can accurately predict recurrence of HPV-driven oropharyngeal cancer following treatment.
Read MoreResearchers developed a blood test for head and neck cancer associated with HPV that was shown to be more accurate and faster than conventional testing.
Read MoreResearchers examined markers of liver cancer and found that the disease can be recognized by RNA fragments in saliva and blood.
Read MoreThe results of research to create an AI-based pathology diagnostic tool with the potential to streamline pathologists’ workloads were recently announced.
Read MoreResearchers have developed a mulitiplex network that reveals underlying mechanisms of rare diseases for more accurate identification of genetic defects.
Read MoreGenetic testing of the siblings of newborns with cancer genes could reduce rare pediatric cancer deaths by about 50%, an NIH-funded analysis suggests.
Read MoreResearch shows that cell-free DNA in cerebrospinal fluid can be used to identify patients at risk of pediatric medulloblastoma relapse.
Read MoreNonagen’s non-invasive bladder cancer test has been granted U.S. Food and Drug Administration (FDA) Breakthrough Device Designation.
Read More